Risk of osteoporosis in thyroid cancer patients using levothyroxine: a population-based study.
CONCLUSION: Our population-based cohort study showed that thyroid cancer patients receiving levothyroxine have a higher risk of osteoporosis.
PMID: 28884595 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Health Insurance | Insurance | Levothyroxine | Orthopaedics | Osteoporosis | Research | Study | Synthroid | Taiwan Health | Thyroid | Thyroid Cancer